Skip to content

Clinical trials

Terminated Lymphoma, Large B-Cell, Diffuse trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lymphoma, Large B-Cell, Diffuse Status: Terminated Country / region: United Kingdom Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20113
20121
20141
20162
20172
20182
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated16

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
Spectrum Pharmaceuticals, Inc2
ADC Therapeutics S.A.1
Autolus Limited1
Bristol-Myers Squibb1
Calithera Biosciences, Inc1
Genmab1
GlaxoSmithKline1
Hoffmann-La Roche1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lymphoma, Large B-Cell, Diffuse16
Lymphoma, Non-Hodgkin4
Lymphoma, T-Cell, Peripheral3
Hodgkin Disease2
Lymphoma, Follicular2
Lymphoma, Large-Cell, Anaplastic2
Lymphoma, Mantle-Cell2
Recurrence2
Burkitt Lymphoma1
Carcinoma, Non-Small-Cell Lung1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.